Patient Story - Michèle and Maris (Myriad Foresight® Carrier Screen)

Although her son Maris appeared healthy after birth, a few days later Michèle could tell something was wrong. Learn how carrier screening could have potentially revealed her son was at-risk for having 21-hydroxylase-deficient congenital adrenal hyperplasia (21-OH CAH) sooner to prepare the family for what lay ahead. Visit cah.counsyl.com to learn more.

[@gto11520]

great and informative video.